Newcastle biotech firm BSF Enterprise has entered a strategic partnership with German consulting firm Schakau Managementberatung to commercialise its bio-engineered skin materials for humanoid and industrial robotics, as well as its lab-grown leather for luxury vehicles. The company announced the move in a statement to shareholders, outlining plans to promote its lab-grown leather products—including the famous T-Rex Leather used in a luxury handbag—to European luxury automotive manufacturers for applications such as interior trim, steering elements, and premium accents.
Expanding into Robotics and Luxury Automotive
BSF's platform enables the production of bio-engineered human skin equivalents, which are advanced biological surface layers designed to provide natural flexibility, structural compatibility, and seamless bio-interface integration. According to the company, traditional synthetic outer layers present performance limitations as humanoid and specialised robotics move toward complex industrial and domestic environments. Schakau will provide access to automotive manufacturers and other potential commercial partners.
The Heads of Terms target a binding memorandum of understanding (MOU) for the development or licensing of Lab-Grown Leather products during September to December 2026. A binding MOU with a Tier-1 partner for Robotics Skin / Biological Interface development is targeted during September 2026 to January 2027.
Commercial Framework and IP Protection
The commercial framework includes a six-year revenue-sharing structure, alongside equity incentives depending on performance. Schakau may also introduce capital, which attracts a success fee of 5% up to £10m, 4% from £10m-£25m, 3% from £25m-£50m, and 2% above £50m, payable in cash or equity on completion. BSF retains 100% ownership of its underlying intellectual property, including patents, tissue scaffolds, trade secrets, and cell-manufacturing processes.
Chief executive Che Connon said: “This strategic partnership represents a significant step in converting our platform science into high-value commercial channels. Entering the ultra-luxury automotive sector gives us direct communication with decision-makers who define luxury craftsmanship, allowing us to commercialise our lab-grown leather in bespoke vehicle programs. Simultaneously, extending our tissue-scaffolding technology into biological interface materials for robotics opens a vast new market opportunity. By applying our expertise in bio-engineered human skin equivalents, we are positioning BSF at the intersection of biotechnology and advanced robotics. We have built a commercial framework that protects our IP while giving our partner every incentive to secure major OEM contracts.”
Industry Perspectives and Future Outlook
Nico Schakau, managing director of Schakau Managementberatung GmbH, added: “For more than two decades, we have worked at the intersection of engineering, advanced materials and the automotive industry. But some ideas have the potential to reach far beyond the industries in which they begin. We believe biological materials could fundamentally change the way humans and machines interact. As humanoid robotics becomes part of our everyday world, the interface between human and machine will matter just as much as the intelligence within it. Tissue engineering opens the door to an entirely new generation of biological interfaces - more natural, more adaptive and ultimately more human. Lab-grown leather gives us an extraordinary opportunity to demonstrate what this technology can achieve today. Robotics gives us a glimpse of what it could become tomorrow.”
The partnership positions BSF to tap into two high-growth markets, with the company aiming to convert its platform science into commercial products. The targeted MOUs with automotive and robotics partners are expected to be finalised over the coming months, setting the stage for potential licensing deals and revenue generation.
